Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$19.52

0.79 (4.22%)

, ESRX

Express Scripts

$70.57

0.51 (0.73%)

09:01
10/11/16
10/11
09:01
10/11/16
09:01

Horizon Pharma sees Q3 adjusted net sales of $272M-$274M, consensus $271.5M

Horizon Pharma (HZNP) estimates, on a GAAP basis including the previously announced $65M settlement with Express Scripts (ESRX) as a one-time reduction in GAAP net sales, its third-quarter 2016 net sales were in the range of $207M-$209M. The company estimates that non-GAAP adjusted net sales, which exclude the $65M settlement with Express Scripts, were in the range of $272M-$274M. The exclusion of the $65 million settlement from GAAP net sales is the only adjustment reflected in third-quarter non-GAAP adjusted net sales. The company expects that Q3 adjusted EBITDA will be in the range of $139M-$141M, which would represent an adjusted EBITDA margin of approximately 51% and sequential quarterly growth versus the second quarter of 2016 of approximately 15%. The company will provide additional information on its Q3 earnings conference call scheduled for November 7.

HZNP

Horizon Pharma

$19.52

0.79 (4.22%)

ESRX

Express Scripts

$70.57

0.51 (0.73%)

  • 26

    Oct

  • 06

    Nov

  • 14

    Dec

HZNP Horizon Pharma
$19.52

0.79 (4.22%)

08/02/16
BMOC
08/02/16
NO CHANGE
BMOC
Outperform
Horizon Pharma scored 'important win' with CVS, says BMO Capital
BMO Capital analyst Gary Nachman said Horizon Pharma (HZNP) securing covered status for Duexis and Vimovo with CVS/Caremark (CVS) is an "important win" for the drugmaker that demonstrates it is improving its execution on the managed care front. While Express Scripts (ESRX) still has Duexis and Vimovo on its exclusion list for 2017, Horizon indicated that it is still in discussions that have been "constructive," noted Nachman, who keeps an Outperform rating on Horizon shares.
09/13/16
BMUR
09/13/16
NO CHANGE
Target $32
BMUR
Buy
Horizon Pharma acquisition a positive, says Brean Capital
Brean Capital analyst Difei Yang said she is positive on Horizon Pharma's (HZNP) deal for Raptor Pharmaceuticals (RPTP). The analyst cited Horizon executing on its transformative strategy into an orphan disease company, the reasonable price paid for the company, and the moderate growth opportunities for synergies between the two. Yang reiterated her Buy rating and raised her price target to $32 from $30 on Horizon Pharma shares.
09/30/16
JMPS
09/30/16
NO CHANGE
JMPS
Horizon Pharma patent loss immaterial, says JMP Securities
After the U.S. Patent and Trademark Office ruled that Horizon Pharma's '215 patent for Ravicti is unpatentable, JMP Securities analyst Donald Ellis says the news is not material. He says that Ravicti still has orphan drug exclusivity until 2020, and that the company has five other patents on the drug that will last until 2032. He recommends buying Horizon on any weakness.
10/03/16
BMOC
10/03/16
NO CHANGE
BMOC
Horizon Pharma added to US Small Cap Fundamental List at BMO Capital
ESRX Express Scripts
$70.57

0.51 (0.73%)

08/09/16
LEER
08/09/16
NO CHANGE
Target $110
LEER
Outperform
Leerink remains positive on CVS Health long-term fundamentals
Leerink analyst David Larsen continues to be positive on CVS' (CVS) long-term fundamentals. The analyst notes that the company is having a successful 2017 selling season, with a retention rate higher than what it was last year, and says its Q3 should benefit from a number of break-even generics. Further, Larsen says the company is being more aggressive than Express Scripts (ESRX) with regards to formulary management, and believes that if CVS provides a 5-year outlook in December, shares will likely rally. Larsen reiterates an Outperform rating and $110 rating on CVS' shares.
08/15/16
LEER
08/15/16
NO CHANGE
LEER
Outperform
Leerink more positive on CVS after Formulary exclusions lists
Leerink analyst David Larsen says he's incrementally more positive on CVS Health (CVS) after the company and Express Scripts (ESRX) published their 2017 National Preferred Formulary exclusions lists. CVS is being more aggressive about using bio-similar products and has excluded about 10 products due to hyperinflation trends, Larsen tells investors in a research note. Express Scripts is excluding around 85 products in 2017, which is almost half of the 153 products being excluded by CVS, the analyst writes. He keeps an Outperform rating on CVS and a Market Perform ration on Express Scripts.
08/29/16
LEER
08/29/16
NO CHANGE
LEER
EpiPen price is Mylan's issue, says Leerink
Leerink analyst David Larsen says the recent weakness in pharmacy benefit managers and the drug distribution group is "overdone," as he believes Mylan (MYL) has been taking the vast majority of the pricing increases that have occurred with EpiPen, not the pharmacy benefit managers and distributors. Further, the analyst estimates that Cardinal Health (CAH) has a "fee-for-service" deal with EpiPen, which means that there may be no benefit to the company for any price increase that occurs, and notes that Express Scripts (ESRX) gives back 80%-90% of EpiPen rebates to their plan customers. Larsen would be a buyer of CVS Health (CVS) on weakness.
10/05/16
UBSW
10/05/16
INITIATION
Target $76
UBSW
Neutral
Express Scripts initiated with a Neutral at UBS
Target $76.

TODAY'S FREE FLY STORIES

LEA

Lear

$187.45

-1.69 (-0.89%)

14:23
01/16/18
01/16
14:23
01/16/18
14:23
Hot Stocks
Lear down over 1% after comments at Deutsche Bank Auto Conference »

Shares of Lear traded as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

BAC

Bank of America

$31.31

0.115 (0.37%)

, GS

Goldman Sachs

$258.28

1.25 (0.49%)

14:20
01/16/18
01/16
14:20
01/16/18
14:20
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$31.31

0.115 (0.37%)

GS

Goldman Sachs

$258.28

1.25 (0.49%)

USB

U.S. Bancorp

$57.28

0.295 (0.52%)

FAST

Fastenal

$55.59

0.5 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

  • 15

    Feb

CSX

CSX

$59.25

0.56 (0.95%)

, IBKR

Interactive Brokers

$63.10

0.66 (1.06%)

14:19
01/16/18
01/16
14:19
01/16/18
14:19
Earnings
Notable companies reporting after market close »

Notable companies…

CSX

CSX

$59.25

0.56 (0.95%)

IBKR

Interactive Brokers

$63.10

0.66 (1.06%)

PNFP

Pinnacle Financial

$68.55

-0.9 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 01

    Mar

SCHW

Charles Schwab

$55.50

0.11 (0.20%)

14:18
01/16/18
01/16
14:18
01/16/18
14:18
Technical Analysis
Technical Earnings Preview: Charles Schwab in active bullish pattern »

The shares are in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
01/16/18
01/16
14:17
01/16/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/16/18
01/16
14:16
01/16/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

, AAPL

Apple

$177.09

1.81 (1.03%)

14:16
01/16/18
01/16
14:16
01/16/18
14:16
Periodicals
Amazon hiring health privacy expert for 'new initiative,' CNBC says »

According to a new job…

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

AAPL

Apple

$177.09

1.81 (1.03%)

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 18

    Mar

URBN

Urban Outfitters

$34.64

0.4 (1.17%)

14:15
01/16/18
01/16
14:15
01/16/18
14:15
Options
Urban Outfitters put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$31.30

0.11 (0.35%)

, GS

Goldman Sachs

$258.51

1.48 (0.58%)

14:14
01/16/18
01/16
14:14
01/16/18
14:14
Earnings
On The Fly: What to watch in bank space earnings reports »

Bank of America (BAC) and…

BAC

Bank of America

$31.30

0.11 (0.35%)

GS

Goldman Sachs

$258.51

1.48 (0.58%)

MS

Morgan Stanley

$54.77

-0.35 (-0.63%)

OSTK

Overstock.com

$78.95

-1.65 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 31

    Jan

  • 15

    Feb

C

Citi

$76.91

0.07 (0.09%)

14:11
01/16/18
01/16
14:11
01/16/18
14:11
Hot Stocks
Citi reports December credit loss 2.58% vs. 2.49% last month »

Reports 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

AMT

American Tower

$137.08

4.08 (3.07%)

14:05
01/16/18
01/16
14:05
01/16/18
14:05
Options
American Tower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

, HD

Home Depot

$197.80

1.38 (0.70%)

14:04
01/16/18
01/16
14:04
01/16/18
14:04
Conference/Events
Wedbush retail/hardlines analyst holds an analyst/industry conference call »

Retail/Hardlines Analyst…

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

HD

Home Depot

$197.80

1.38 (0.70%)

LOW

Lowe's

$101.57

0.71 (0.70%)

W

Wayfair

$86.58

1 (1.17%)

WSM

Williams-Sonoma

$54.24

-1.25 (-2.25%)

BBBY

Bed Bath & Beyond

$22.82

0.83 (3.77%)

TPX

Tempur Sealy

$65.02

1.07 (1.67%)

AZO

AutoZone

$784.20

-3.73 (-0.47%)

AAP

Advance Auto Parts

$114.41

-1.53 (-1.32%)

ORLY

O'Reilly Automotive

$258.60

-1.15 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 08

    Feb

  • 18

    Feb

  • 20

    Feb

  • 22

    Feb

  • 18

    Mar

HRB

H&R Block

$26.52

0.155 (0.59%)

, WMT

Walmart

$101.06

0.19 (0.19%)

14:03
01/16/18
01/16
14:03
01/16/18
14:03
Hot Stocks
H&R Block to be exclusive DIY desktop tax software provider available at Walmart »

H&R Block (HRB) and…

HRB

H&R Block

$26.52

0.155 (0.59%)

WMT

Walmart

$101.06

0.19 (0.19%)

INTU

Intuit

$164.51

1.51 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 20

    Feb

OGE

OGE Energy

$30.95

0.21 (0.68%)

14:02
01/16/18
01/16
14:02
01/16/18
14:02
Hot Stocks
OG&E says customers to benefit from federal tax reform in its rate filing »

Oklahoma Gas and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRB

H&R Block

$26.50

0.14 (0.53%)

, WMT

Walmart

$101.07

0.2 (0.20%)

14:01
01/16/18
01/16
14:01
01/16/18
14:01
Hot Stocks
Breaking Hot Stocks news story on H&R Block, Walmart »

H&R Block to be…

HRB

H&R Block

$26.50

0.14 (0.53%)

WMT

Walmart

$101.07

0.2 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

VST

Vistra Energy

$18.18

-0.39 (-2.10%)

14:00
01/16/18
01/16
14:00
01/16/18
14:00
Hot Stocks
Qatar Investment Authority reports 5.34% passive stake in Vistra Energy »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$188.40

-0.74 (-0.39%)

13:59
01/16/18
01/16
13:59
01/16/18
13:59
Hot Stocks
Lear falls after saying not planning to split company by segments »

Comments made on company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

13:55
01/16/18
01/16
13:55
01/16/18
13:55
Conference/Events
Cowen healthcare policy analyst holds an analyst/industry conference call »

Healthcare Policy Analyst…

SQ

Square

$39.65

-1.605 (-3.89%)

13:53
01/16/18
01/16
13:53
01/16/18
13:53
Conference/Events
Cantor Fitzgerald fintech analysts hold an analyst/industry conference call »

Analysts, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQM

SQM

$58.61

-4.12 (-6.57%)

13:52
01/16/18
01/16
13:52
01/16/18
13:52
Recommendations
SQM analyst commentary  »

SQM selloff is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.61

0.03 (0.03%)

13:50
01/16/18
01/16
13:50
01/16/18
13:50
Options
Defensive option play in the High Yield Bond ETF »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$87.35

0.525 (0.60%)

, XLP

Consumer Staples Sector SPDR

$57.00

0.345 (0.61%)

13:46
01/16/18
01/16
13:46
01/16/18
13:46
Technical Analysis
Technical Take: S&P 500 back to near flat-line, sector breadth negative »

The S&P 500 (SPX) was…

XLV

Health Care Select Sector SPDR

$87.35

0.525 (0.60%)

XLP

Consumer Staples Sector SPDR

$57.00

0.345 (0.61%)

XLE

Energy Select Sector SPDR

$76.96

-0.46 (-0.59%)

XLI

Industrial Select Sector SPDR

$79.96

-0.21 (-0.26%)

XLB

S&P Select Materials SPDR

$62.95

-0.445 (-0.70%)

SPY

SPDR S&P 500 ETF Trust

$278.37

0.45 (0.16%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$15.18

0.06 (0.40%)

13:45
01/16/18
01/16
13:45
01/16/18
13:45
Options
Barrick Gold call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 22

    Feb

13:45
01/16/18
01/16
13:45
01/16/18
13:45
General news
Fedspeak resumes on Wednesday along with a Senate vote on Powell »

Fedspeak resumes on…

RACE

Ferrari

$118.57

0.73 (0.62%)

, TSLA

Tesla

$336.22

-1.73 (-0.51%)

13:41
01/16/18
01/16
13:41
01/16/18
13:41
Periodicals
Ferrari plans electric supercar amid lineup expansion, Automotive News reports »

Ferrari (RACE) is…

RACE

Ferrari

$118.57

0.73 (0.62%)

TSLA

Tesla

$336.22

-1.73 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.